Literature DB >> 6839926

The epidemiology of lower extremity amputations in diabetic individuals.

R S Most, P Sinnock.   

Abstract

The Diabetes Control Activity has established diabetes control programs in 20 states. Each has investigated the extent and nature of diabetes morbidity within its state by means of a descriptive analysis of selected health status indicators. Data from six states are included: 100% of hospital discharges from Rhode Island, South Carolina, and Maine and approximately 50% from Minnesota, Illinois, and Ohio were pooled to provide a profile of lower extremity amputations (LEA) in diabetic individuals. The purposes of this study were to identify diabetic persons at high risk of amputation for targeting preventive programs as well as to establish a baseline for monitoring trends over time. Discharge data provided by hospital abstracting services were examined for 1976-1978. Results indicate that 45% of all LEAs are performed on patients with diabetes. An age-adjusted LEA rate of 59.7/10,000 diabetic individuals was computed. Diabetes-related amputation rates increase with age and are higher in males. The overwhelming majority of LEAs are either toe or above the knee, with few performed on the foot. The relative risk of LEAs for the diabetic compared with the nondiabetic population is highest in the under-45 age group (28), although the attributable risk is highest in the older population (91.5/10,000 diabetic individuals). Overall, diabetic persons have a 15 times higher risk of LEA than nondiabetic individuals.

Entities:  

Mesh:

Year:  1983        PMID: 6839926     DOI: 10.2337/diacare.6.1.87

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  53 in total

1.  Impaired biomechanical properties of diabetic skin implications in pathogenesis of diabetic wound complications.

Authors:  Dustin M Bermudez; Benjamin J Herdrich; Junwang Xu; Robert Lind; David P Beason; Marc E Mitchell; Louis J Soslowsky; Kenneth W Liechty
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Iloprost and peripheral arterial disease in diabetic patients.

Authors:  A M Vicari; R Chiesa; G Mari; M Galimberti; V Di Carlo; G Pozza
Journal:  Acta Diabetol Lat       Date:  1991 Jan-Mar

3.  Outcomes of allogenic acellular matrix therapy in treatment of diabetic foot wounds: an initial experience.

Authors:  Billy R Martin; Melinda Sangalang; Stephanie Wu; David G Armstrong
Journal:  Int Wound J       Date:  2005-06       Impact factor: 3.315

Review 4.  Endovascular techniques in limb salvage: infrapopliteal angioplasty.

Authors:  Joseph J Naoum; Elias J Arbid
Journal:  Methodist Debakey Cardiovasc J       Date:  2013-04

Review 5.  Angiogenesis and vasculogenesis in treatment of cardiovascular disease.

Authors:  A Rivard; J M Isner
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

Review 6.  The role of diversity in the health care needs of California.

Authors:  M V Drake; D H Lowenstein
Journal:  West J Med       Date:  1998-05

Review 7.  Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis.

Authors:  Joe F Lau; Mitchell D Weinberg; Jeffrey W Olin
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

8.  Fixing a hole: CCN2 closes chronic wounds.

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2015-04-22       Impact factor: 5.782

Review 9.  The epidemiology of neuropathic foot ulcers in individuals with diabetes.

Authors:  Jay Sosenko
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 10.  Approach to managing diabetic foot ulcers.

Authors:  John A A Nesbitt
Journal:  Can Fam Physician       Date:  2004-04       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.